{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:38:13Z","timestamp":1780393093022,"version":"3.54.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T00:00:00Z","timestamp":1395360000000},"content-version":"vor","delay-in-days":201,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"PHS","award":["K08 AG-22228"],"award-info":[{"award-number":["K08 AG-22228"]}]},{"name":"Dominantly Inherited Alzheimer Network","award":["U19 AG-032438"],"award-info":[{"award-number":["U19 AG-032438"]}]},{"name":"UCLA Clinical Translational Research Institute","award":["1UL1-RR033176"],"award-info":[{"award-number":["1UL1-RR033176"]}]},{"name":"Alzheimer's Disease Research Center","award":["P50 AG-16570"],"award-info":[{"award-number":["P50 AG-16570"]}]},{"name":"General Clinical Research Centers Program","award":["M01-RR00865"],"award-info":[{"award-number":["M01-RR00865"]}]},{"name":"Easton Consortium for Alzheimer's Disease Drug Discovery and Biomarker Development"}],"content-domain":{"domain":["contemporaryclinicaltrials.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.cct.2013.07.006","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T06:31:36Z","timestamp":1374215496000},"page":"256-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Megan","family":"Hooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaneth","family":"Rodriguez-Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis D.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"Alvarez-Retuerto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Ringman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9503","key":"10.1016\/j.cct.2013.07.006_bb0005","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"issue":"11 Suppl. 5","key":"10.1016\/j.cct.2013.07.006_bb0010","first-page":"S10","article-title":"Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group","volume":"54","author":"Fratiglioni","year":"2000","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.cct.2013.07.006_bb0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.cct.2013.07.006_bb0020","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","article-title":"Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset","volume":"88","author":"Brookmeyer","year":"1998","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.cct.2013.07.006_bb0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jalz.2008.09.004","article-title":"Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results","volume":"5","author":"Meinert","year":"2009","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.cct.2013.07.006_bb0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10048-006-0053-1","article-title":"The A431E mutation in PSEN1 causing Familial Alzheimer's Disease originating in Jalisco State, Mexico: an additional fifteen families","volume":"7","author":"Murrell","year":"2006","journal-title":"Neurogenetics"},{"issue":"3 Suppl. 2","key":"10.1016\/j.cct.2013.07.006_bb0035","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/00002093-200607001-00015","article-title":"Prevention of Alzheimer disease","volume":"20","author":"Thal","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"10.1016\/j.cct.2013.07.006_bb0040","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"Pt 3","key":"10.1016\/j.cct.2013.07.006_bb0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/brain\/120.3.491","article-title":"Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor","volume":"120","author":"Fox","year":"1997","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.cct.2013.07.006_bb0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11910-004-0081-x","article-title":"Genetics and genetic counseling: recommendations for Alzheimer's disease, frontotemporal dementia, and Creutzfeldt-Jakob disease","volume":"4","author":"Williamson","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"10.1016\/j.cct.2013.07.006_bb0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jalz.2008.12.002","article-title":"Commentary on \u201ca roadmap for the prevention of dementia II: Leon Thal Symposium 2008.\u201d Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges","volume":"5","author":"Ringman","year":"2009","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.cct.2013.07.006_bb0060","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1001\/archneur.58.11.1828","article-title":"Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia","volume":"58","author":"Steinbart","year":"2001","journal-title":"Arch Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2013.07.006_bb0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris","year":"1997","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"10.1016\/j.cct.2013.07.006_bb0070","first-page":"304","article-title":"A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning","volume":"12","author":"Koehly","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl. 3","key":"10.1016\/j.cct.2013.07.006_bb0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-2011-0059","article-title":"Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments","volume":"26","author":"Reiman","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.cct.2013.07.006_bb0080","first-page":"35","article-title":"Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease","volume":"2","author":"Bateman","year":"2011","journal-title":"Alzheimers Res Ther"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714413001171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714413001171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T22:04:55Z","timestamp":1563487495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714413001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1551714413001171"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2013.07.006","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2013.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}